Skip to main
BIOX
BIOX logo

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions Corp has demonstrated resilience with its crop protection portfolio, particularly benefiting from strong performance outside Argentina, which is expected to enhance overall revenue growth as Argentine farmer demand potentially rebounds. The company remains well-positioned to leverage robust international opportunities, notably for its HB4 wheat revenue in key markets such as the US, Brazil, and Australia, although revenue growth is anticipated to take time as partnerships are established. Furthermore, despite weaker results in Argentina, the steady momentum from bio-protection products and increased adjuvant sales in other regions has helped mitigate the impact of domestic market challenges, reinforcing a positive outlook on the company's diversified revenue streams.

Bears say

Bioceres Crop Solutions Corp has experienced a significant decline in revenues, with a notable decrease in Crop Nutrition and Seed & Integrated products, which fell approximately 34% and 75% year-over-year, respectively. The company’s transition to a licensing-based business model, moving away from direct seed production and sales, has resulted in diminished contributions from its HB4-related sales, further exacerbating revenue losses. Weak demand in Argentina, compounded by pricing pressures and reduced corn acreage, underscores the challenges the company faces in sustaining growth in its primary markets.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.